Filtros de búsqueda

Lista de obras de

A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer ⬇️

artículo científico publicado el 26 de julio de 2012

A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study

artículo científico publicado en 2009

A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer

artículo científico publicado en 2014

A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma

artículo científico publicado en 2012

A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma

scientific article published on 05 September 2015

A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer ⬇️

artículo científico publicado el 17 de octubre de 2012

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer

artículo científico publicado en 2009

A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum‐sensitive ovarian cancer ⬇️

artículo científico publicado el 9 de noviembre de 2011

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study

article

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study

artículo científico publicado en 2010

A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy ⬇️

artículo científico publicado el 25 de abril de 2013

A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube

artículo científico publicado en 2014

A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): a Gynecologic Oncology Group Study

artículo científico publicado en 2008

ASCO Value Framework Highlights the Relative Value of Treatment Options in Ovarian Cancer

artículo científico publicado en 2017

Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer

artículo científico publicado en 2011

An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).

artículo científico publicado en 2009

Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis

artículo científico publicado en 2016

Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer

artículo científico

Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology G

artículo científico publicado en 2009

Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma

Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists

artículo científico publicado en 2009

Cervical cancer

artículo científico publicado en 2008

Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study

artículo científico publicado en 2017

Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study

artículo científico publicado en 2007

Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.

artículo científico publicado en 2015

Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer

artículo científico publicado en 2017

Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer ⬇️

artículo científico publicado el 12 de julio de 2011

Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer

artículo científico publicado en 2013

Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

artículo científico publicado en 2008

Cost-Effectiveness of BRCA1 and BRCA2 Mutation Testing to Target PARP Inhibitor Use in Platinum-Sensitive Recurrent Ovarian Cancer ⬇️

artículo científico publicado el 1 de junio de 2013

Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer ⬇️

artículo científico publicado el 14 de junio de 2013

Cost‐effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum‐sensitive, recurrent ovarian cancer ⬇️

artículo científico publicado el 19 de mayo de 2011

Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan, and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expression

artículo científico publicado en 2014

Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines

artículo científico publicado en 2014

Disparities in the surgical staging of high-grade endometrial cancer in the United States

artículo científico publicado en 2017

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study

artículo científico publicado en 2016

Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis

artículo científico publicado en 2015

Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial

artículo científico publicado en 2011

High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease ⬇️

artículo científico publicado el 1 de octubre de 2003

Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study

artículo científico publicado en 2009

Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: A Gynecologic Oncology Group Study ⬇️

artículo científico publicado el 24 de mayo de 2012

Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma

scientific article published on 01 March 2006

Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancer

artículo científico publicado en 2015

MHC Class I–Presented Tumor Antigens Identified in Ovarian Cancer by Immunoproteomic Analysis Are Targets for T-Cell Responses against Breast and Ovarian Cancer ⬇️

artículo científico publicado el 7 de febrero de 2011

Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?

artículo científico publicado en 2017

Management of platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis

artículo científico publicado en 2007

Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study

artículo científico publicado en 2006

Medical and surgical treatment of placenta percreta to optimize bladder preservation

artículo científico publicado en 2008

Metformin is associated with improved survival in endometrial cancer

artículo científico publicado en 2013

Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome

artículo científico publicado en 2009

Minimally Invasive Surgery for Endometrial Cancer: The Horse Is Already out of the Barn ⬇️

artículo científico publicado el 30 de enero de 2012

Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: A multi-site study performed at high volume cancer centers

artículo científico publicado en 2012

Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer

scientific article published on 15 May 2009

Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer

artículo científico publicado en 2013

Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes

artículo científico publicado en 2017

Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer

artículo científico publicado en 2014

Obesity: Too big a problem to ignore

artículo científico publicado el 30 de abril de 2012

Outcomes in surgical stage I uterine papillary serous carcinoma

artículo científico publicado en 2007

Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial

artículo científico publicado en 2017

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

artículo científico publicado en 2006

Performance of sentinel lymph node biopsy in high-risk endometrial cancer

artículo científico publicado en 2016

Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study

artículo científico publicado en 2008

Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study

artículo científico publicado en 2011

Physical strain and urgent need for ergonomic training among gynecologic oncologists who perform minimally invasive surgery ⬇️

artículo científico publicado el 18 de mayo de 2012

Predicting 6- and 12-Month Risk of Mortality in Patients With Platinum-Resistant Advanced-Stage Ovarian Cancer: Prognostic Model to Guide Palliative Care Referrals

artículo científico publicado en 2018

Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer ⬇️

artículo científico publicado el 21 de diciembre de 2012

Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer ⬇️

artículo científico publicado el 15 de marzo de 2012

Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis

artículo científico publicado en 2007

Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma

artículo científico publicado en 2017

Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer

artículo científico publicado en 2014

Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer

artículo científico

Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer

artículo científico publicado en 2004

Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer

artículo científico publicado en 2007

Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidity

artículo científico publicado en 2005

Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients

artículo científico publicado en 2014

Relationship between tamoxifen use and high risk endometrial cancer histologic types

artículo científico publicado en 2008

Resection of lymph node metastases influences survival in stage IIIC endometrial cancer

artículo científico publicado en 2005

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

artículo científico publicado en 2005

Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma ⬇️

artículo científico publicado el 13 de julio de 2011

Robotic-assisted laparoscopic gynecologic procedures in a fellowship training program

artículo científico publicado en 2009

SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm

artículo científico publicado en 2014

Safety and feasibility of contained uterine morcellation in women undergoing laparoscopic hysterectomy

Severe ulceration over mandibular torus in an ovarian cancer patient receiving bevacizumab therapy

artículo científico publicado en 2011

Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence

scientific article published on 28 October 2009

Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes

scientific article published on 01 January 2009

Surgical staging for endometrial cancer in the elderly — Is there a role for lymphadenectomy? ⬇️

artículo científico publicado el 12 de mayo de 2012

Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study

artículo científico publicado en 2016

TP53 Status is Associated with Thrombospondin1 Expression In vitro

artículo científico publicado en 2013

The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance

artículo científico publicado en 2014

The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer

artículo científico publicado en 2011

The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer

scientific article published on 02 October 2006

The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer

scientific article published on 01 July 2004

The role of PET scanning in the detection of recurrent cervical cancer

artículo científico publicado en 2003

The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma

artículo científico publicado en 2009

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer

artículo científico publicado en 2007

The role of optimal debulking in advanced stage serous carcinoma of the uterus

artículo científico publicado en 2004

The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer

artículo científico

Tumor grade and chemotherapy response in endometrioid endometrial cancer

artículo científico publicado en 2016

Urinary diversion in the genitourinary cancer survivor

artículo científico publicado en 2017

Vaginal cuff thermal injury by mode of colpotomy at total laparoscopic hysterectomy: a randomized clinical trial

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda